Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry
- 31 July 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 46 (1) , 55-61
- https://doi.org/10.1016/0090-8258(92)90196-p
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The effects of provera on chemotherapy of uterine cancer cell linesGynecologic Oncology, 1991
- Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceGynecologic Oncology, 1990
- Synergistic effects of cis-platinum and cystosine arabinoside on ovarian carcinoma cell lines, demonstrated by dual-parameter flow cytometryGynecologic Oncology, 1989
- Influence of Fetal Calf Serum in Combination with Pharmacological Doses of Progesterone or Estradiol on Proliferation and Cell Cycle Kinetics of Cultured Mammary Cancer CellsOncology, 1989
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 1987
- The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viabilityEuropean Journal of Cancer and Clinical Oncology, 1987
- Melphalan, 5-Fluorouracil, and Medroxyprogesterone Acetate in Metastatic Endometrial CarcinomaObstetrics & Gynecology, 1986
- Treatment of advanced or recurrent endometrial carcinoma with medroxyprogesterone acetate (MPA): A gynecologic oncology group studyGynecologic Oncology, 1985
- Gestagens and endometrial carcinomaGynecologic Oncology, 1976